acepromazine has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bubenik, GA; Parker, GH; Persinger, MA; St-Pierre, LS | 1 |
| Blomme, CG; Dupont, MJ; George, KR; Mazzuchin, A; Persinger, MA; Rico, T; St-Pierre, LS; Stewart, LS | 1 |
| Cone, FE; Kalesnykas, G; Oglesby, EN; Pease, ME; Quigley, HA; Steinhart, MR | 1 |
| Persinger, MA; St-Pierre, LS | 1 |
| Anderson, ME; Khoo, M; Madu, EC; Ni, G; Rottman, JN; Wang, Z; Zhang, W | 1 |
| Fournier, NM; Persinger, MA | 1 |
| Keith, SJ; Nurnberg, HG; Paxton, DM | 1 |
8 other study(ies) available for acepromazine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Insidious weight gain in prepubertal seized rats treated with an atypical neuroleptic: the role of food consumption, fluid consumption, and spontaneous ambulatory activity.
Topics: Acepromazine; Analysis of Variance; Animals; Antipsychotic Agents; Body Weight; Disease Models, Animal; Drinking; Eating; Epilepsy; Female; Lithium Chloride; Obesity; Pilocarpine; Rats; Rats, Wistar; Weight Gain | 2009 |
Large differences in blood measures, tissue weights, and focal areas of damage 1 year after postseizure treatment with acepromazine or ketamine.
Topics: Acepromazine; Analysis of Variance; Animals; Blood Pressure; Brain; Disease Models, Animal; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Ketamine; Lithium Chloride; Longitudinal Studies; Male; Neurologic Examination; Organ Size; Pilocarpine; Rats; Rats, Wistar; Seizures; Statistics as Topic; Thyroid Gland | 2009 |
The effects of anesthesia, mouse strain and age on intraocular pressure and an improved murine model of experimental glaucoma.
Topics: Acepromazine; Aging; Anesthesia; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Axons; Cell Count; Disease Models, Animal; Glaucoma; Injections, Intraperitoneal; Intraocular Pressure; Isoflurane; Ketamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microspheres; Optic Nerve Diseases; Retinal Ganglion Cells; Species Specificity; Viscosupplements; Xylazine | 2012 |
The brain matrix and multifocal brain damage following a single injection of ketamine in young adult rats: conspicuous changes in old age.
Topics: Acepromazine; Age Factors; Animals; Brain; Brain Damage, Chronic; Disease Models, Animal; Ketamine; Lithium; Male; Neurons; Pilocarpine; Rats; Rats, Wistar; Seizures | 2002 |
Temporal changes in ventricular function assessed echocardiographically in conscious and anesthetized mice.
Topics: Acepromazine; Adrenergic alpha-Agonists; Age Factors; Anesthesia; Anesthetics; Animals; Body Weight; Cardiac Output; Consciousness; Diastole; Disease Models, Animal; Dopamine Antagonists; Echocardiography; Female; Heart Rate; Heart Ventricles; Injections, Intraperitoneal; Ketamine; Male; Mice; Mice, Inbred C57BL; Models, Cardiovascular; Multivariate Analysis; Predictive Value of Tests; Reference Values; Regression Analysis; Reproducibility of Results; Sex Factors; Statistics as Topic; Systole; Time Factors; Ventricular Function; Xylazine | 2003 |
The neuromatrix and the epileptic brain: behavioral and learning preservation in limbic epileptic rats treated with ketamine but not acepromazine.
Topics: Acepromazine; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Chi-Square Distribution; Conditioning, Psychological; Disease Models, Animal; Epilepsy; Escape Reaction; Excitatory Amino Acid Antagonists; Exploratory Behavior; Fear; Ketamine; Lithium Chloride; Male; Maze Learning; Rats; Rats, Wistar; Seizures; Time Factors | 2004 |
Consideration of the relevance of ethological animal models for human repetitive behavioral spectrum disorders.
Topics: Acepromazine; Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Ethology; Female; Horse Diseases; Horses; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Opioid Peptides; Paroxetine; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serotonin; Stereotyped Behavior; Stress, Psychological | 1997 |